Ophthalmology

Top Story

De-escalating dose of bevacizumab may be effective in treating ROP

November 22, 2017

NEW ORLEANS — A dose of intravitreal bevacizumab as low as 0.031 mg was successful in treating acute, severe retinopathy of prematurity in a small cohort of infant patients, a speaker said here.

“Doses as low as 5% of what was used and considered the standard dose in the BEAT-ROP study were successful in nine out of nine infants, although some infants required additional treatment,” David K. Wallace, MD, MPH, said at the American Academy of Ophthalmology meeting.

Meeting NewsVideo

VIDEO: Aesthetic lower eyelid surgery minimally invasive for best results

November 22, 2017
NEW ORLEANS ― At the American Academy of Ophthalmology meeting here, David B.
Meeting NewsVideo

Xen gel stent ‘transformative’ to glaucoma practice

November 21, 2017
NEW ORLEANS ― At the American Academy of Ophthalmology meeting here, Nathan Radcliffe, MD, of New York Eye and Ear, discusses his implementation of the Allergan Xen gel…

Second Sight reports $6.7 million quarterly net loss

November 21, 2017
Second Sight Medical Products reported a net loss of $6.7 million, or $0.12 per share, in the third quarter of 2017 compared with a net loss of $8.5 million, or $0.20…
Meeting News

Working with clinical trials a common theme for KOL migration into industry

November 21, 2017
NEW ORLEANS — A large number of doctors are joining companies as chief medical officers, OSN Chief Medical Editor Richard L. Lindstrom, MD, said in remarks at the…
More Headlines »
Original Article

Unilateral Congenital Cataract: Clinical Profile and Presentation

Journal of Pediatric Ophthalmology and Strabismus
Online Advanced Release, November 14, 2017
To study the clinical profile and presentation of children with unilateral cataract. In this hospital-based…
More »
CME

EDUCATION FOR THE TREATING EYE CARE SPECIALIST

Updates on the Treatment of Myopic Choroidal Neovascularization: Earlier Intervention is Better

This activity is supported by an educational grant from Genentech, Inc.

This educational activity is a 1-hour interactive webinar directed to the needs of retina specialists and comprehensive…
More »
Resource Centers
American Academy of Ophthalmology Meeting

American Academy of Ophthalmology Meeting

Video
Meeting News

VIDEO: Lucentis superior to PDT for treating myopic CNVM

November 19, 2017
More »